Celldex Therapeutics (CLDX) Tax Rate (2017 - 2021)

Celldex Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 1.1% for Q3 2021.

• On a quarterly basis, Tax Rate changed N/A year-over-year to 1.1% in Q3 2021; TTM through Dec 2021 was 0.95%, a 902.0% decrease from a year earlier, with the FY2023 full-year figure at 21.0%, changed 0.0% from the prior year.
• Tax Rate advanced to 1.1% in Q3 2021 per CLDX's latest filing, from 3.94% in the prior quarter.
• Across five years, Tax Rate topped out at 83.24% in Q4 2017 and bottomed at 3.94% in Q4 2020.
• The 4-year median for Tax Rate is 1.44% (2020), against an average of 19.89%.
• Biggest YoY gain for Tax Rate was 2325 bps in 2018; the steepest drop was 2325 bps in 2018.
• Year by year, Tax Rate stood at 83.24% in 2017, then declined by 28 bps to 59.99% in 2018, then tumbled by 107 bps to 3.94% in 2020, then surged by 128 bps to 1.1% in 2021.
• Per Business Quant, the three latest CLDX Tax Rate figures stand at 1.1% (Q3 2021), 3.94% (Q4 2020), and 1.78% (Q2 2020).